Education ▼

PER is hosting the 2nd Annual International Congress on Oncology Pathology^™ | June 23rd in NYC Hematologic Malignancies Medical Crossfire in NYC on July 14th! Register today!

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Gastrointestinal Cancer

Mantle Cell Lymphoma

Expert Discusses Venetoclax Potential in MCL

Toby Eyre, MBChB, MRCP, discusses the results of the phase I study with venetoclax in patients with poor-risk relapsed/refractory mantle cell lymphoma.
Read More >>

CAR T-Cell Therapy Explored in Mantle Cell Lymphoma

Ibrutinib/Buparlisib Reaches Response in Half of NHL Cohort

CDK4/6 Inhibition Shows Early Promise in Mantle Cell Lymphoma

CAR T-Cell Therapy Starts to Enter MCL Space

Taking the Next Step in MCL: Novel Combos and Immunotherapy Under Study

View More Stories >>

View Conference Coverage

2018 World Congress on GI Cancer

2018 European Hematology Association Congress

2018 State of the Science Summit on Genitourinary Cancers

2018 ASCO Annual Meeting

2018 ASPHO Conference

Dr. Goy on Prognostic Markers in Mantle Cell Lymphoma

Dr. Wang Discusses the ZUMA-2 Trial in Mantle Cell Lymphoma

Dr. Hilal Discusses Rituximab Maintenance in Mantle Cell Lymphoma

Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL

Dr. Goy Discusses the Evolution of Treatment for MCL

Dr. Leslie Discusses Advancements in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

How to Properly Utilize MRD Testing

Emerging Agents for Mantle Cell Lymphoma

Acalabrutinib for Treating Mantle Cell Lymphoma

Ongoing Challenges in Treating Mantle Cell Lymphoma

$Treating Relapsed/Refractory Mantle Cell Lymphoma$

Role of Maintenance Therapy in Mantle Cell Lymphoma

Response Assessment in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Cervical Cancer, Ovarian Cancer, and CLL, and More